BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11958767)

  • 1. [Tetrabamate and a benefit-risk ratio].
    Isabel Lucena M; Andrade RJ; García-Ruiz E; Madurga M
    Med Clin (Barc); 2002 Apr; 118(12):477. PubMed ID: 11958767
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tetrabamate in the treatment of agoraphobia].
    Iruela Cuadrado LM; García Páez JM
    Med Clin (Barc); 1988 Nov; 91(18):717. PubMed ID: 3230993
    [No Abstract]   [Full Text] [Related]  

  • 3. [Double-blind study of the efficacy of tetrabamate and tiapride in the treatment of alcohol deprivation syndrome].
    Santo Domingo Carrasco J; Bravo Ortiz MF; Barroso Cañizares A; Caballero Martín L
    Med Clin (Barc); 1985 Oct; 85(13):533-6. PubMed ID: 3908847
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anxiolytic efficacy and tolerance of tetrabamate in anxious patients abusing alcohol. Multicenter double-blind versus placebo study].
    Lôo H; Guelfi JD; Malka R; Brion S; Cottin M; Gailledreau J; Raab A; Salfati M; Sarda A; Godchau M
    Encephale; 1986; 12(5):291-7. PubMed ID: 3545785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A controlled double-blind study of tetrabamate versus lorazepam and placebo in generalized anxiety].
    Lôo H; Malka R; Hantouche E; Lancrenon S; Guelfi JD
    Encephale; 1991; 17(4):295-300. PubMed ID: 1959498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double blind study on the efficacy and safety of tetrabamate and chlordiazepoxide in the treatment of the acute alcohol withdrawal syndrome.
    Radouco-Thomas S; Garcin F; Guay D; Marquis PA; Chabot F; Huot J; Chawla S; Forest JC; Martin S; Stewart G
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):55-75. PubMed ID: 2664886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute liver failure following tetrabamate].
    Binder D; Jost R; Flury R; Salomon F
    Schweiz Med Wochenschr; 1995 May; 125(19):965-9. PubMed ID: 7761807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tetrabamate-induced hepatotoxicity. Report of seven cases and literature review].
    López-Torres E; Lucena MI; Andrade RJ; García Ruiz E; Fernández MC; Peláez G; Soria de la Cruz MJ; Pizarro A
    Gastroenterol Hepatol; 2002 Dec; 25(10):589-93. PubMed ID: 12459120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of Atrium 300 in the withdrawal of alcoholic patients].
    Fontan M; Taine D
    Therapeutique; 1973; 49(7):463-6. PubMed ID: 4595358
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of the psychosyndrome of alcoholic withdrawal using Atrium].
    Descloux A
    Rev Med Suisse Romande; 1971 Jan; 91(1):57-62. PubMed ID: 5164795
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anxiolytic agents in alcoholism].
    Rodríguez-Martos A
    Aten Primaria; 1994 Mar; 13(5):260-4. PubMed ID: 7654926
    [No Abstract]   [Full Text] [Related]  

  • 12. [A double blind comparative study of atrium 300 and heminiurine in chronic alcoholics].
    Teijeiro J
    Med Hyg (Geneve); 1975 Oct; 33(1164):1441-2. PubMed ID: 768722
    [No Abstract]   [Full Text] [Related]  

  • 13. [A comparative double-blind study of atrium 300 and hemineurine in chronic alcoholics (author's transl)].
    Teijeiro J
    Schweiz Rundsch Med Prax; 1976 Apr; 65(14):420-2. PubMed ID: 981161
    [No Abstract]   [Full Text] [Related]  

  • 14. [The test of serum GGT decrease after alcoholic withdrawal. Study in 221 patients treated with Atrium].
    Latrive JP; Lemoine JP; Forget P
    Therapie; 1987; 42(2):246-7. PubMed ID: 2887044
    [No Abstract]   [Full Text] [Related]  

  • 15. [Severe acute hepatitis caused by Atrium].
    Brocheriou I; Zafrani ES; Mavier P
    Gastroenterol Clin Biol; 1993; 17(4):305-6. PubMed ID: 8339895
    [No Abstract]   [Full Text] [Related]  

  • 16. [Atrium-induced hepatitis with autoimmune pattern].
    Pariente EA; Mineur D
    Gastroenterol Clin Biol; 1992; 16(5):485-6. PubMed ID: 1526409
    [No Abstract]   [Full Text] [Related]  

  • 17. [When drug withdrawal for safety concerns may be harmful. A case report with tetrabamate].
    Raveloarimisy L; Gras-Champel V; Lemaire-Nanni E; Burde-Hamm F; Andréjak M; Guilbaud JC
    Therapie; 2002; 57(6):593-5. PubMed ID: 12666269
    [No Abstract]   [Full Text] [Related]  

  • 18. [Stevens-Johnson syndrome induced by tetrabamate in a patient with HIV infection].
    Lleonart R; Nomdedeu J; Sambeat MA
    Med Clin (Barc); 1992 Oct; 99(12):474. PubMed ID: 1460902
    [No Abstract]   [Full Text] [Related]  

  • 19. [Acute hepatitis associated with microvesicular steatosis induced by Atrium].
    Schneider S; Charles F; Chichmanian RM; Montoya ML; Rampal P
    Gastroenterol Clin Biol; 1995 Dec; 19(12):1064-5. PubMed ID: 8729422
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of 5-butyl-1-cyclohexyl-2,4,6,-trioxoperidropyrimidine (BCP) in the prevention and therapy of neonatal hyperbilirubinemia. Comparative study with phenobarbital].
    Centa A; Camera G; Piccinini A; De Pietro P; Tomatis C
    Minerva Pediatr; 1976 Apr; 28(15):911-21. PubMed ID: 11400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.